Teva Pharmaceutical Industries Ltd.'s (NYSE:TEVA) first-quarter earnings fell 27% as the drug maker saw a sharp drop in generic-medicine sales. Israel-based Teva has grown through a series of acquisitions to become the world's largest maker of generic ...
See all stories on this topic »
↧
Teva profit falls on lower generic sales Alerts - "Teva Pharmaceutical Industries Ltd."
↧